<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Groningen_Template_MODULE_Project_secretion"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:Groningen/Template/MODULE/Project/secretion">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Groningen/Template/MODULE/Project/secretion&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Groningen/Template/MODULE/Project/secretion&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Groningen/Template/MODULE/Project/secretion&amp;action=history">History               </A></LI><LI style="color:white;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Groningen/Template/MODULE/Project/secretion" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Groningen/Template/MODULE/Project/secretion</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2014.igem.org</H3><DIV class="entry gridcell grid"><DIV class="module breadcrummodule gridcell"><DIV class="content"><DIV class="wrapper"><SPAN class="tail">Project</SPAN><SPAN class="seperator">&gt;</SPAN><SPAN class="head">Secretion</SPAN><DIV class="hspacer"> </DIV></DIV><DIV class="hspacer"> </DIV></DIV><DIV class="hspacer"> </DIV></DIV><DIV class="module contentmodule gridcell"><DIV class="content"><DIV class="wrapper"><DIV class="title">
The secreting system
</DIV><DIV class="text">
In order to exterminate the <I>Pseudomonas aeruginosa</I> and <I>Staphylococcus aureus</I>, the genetically engineered <I>Lactococcus lactis</I> NZ9800 needs to secrete a couple of infection preventing molecules. For <I>P. aeruginosa</I> these molecules will be Dispersin B and AHL lactonase, coded by the genes <I>dspB</I> and <I>aiiA</I>. For <I>S. aureus</I> these molecules will be Dispersin B and nisin coded by the genes <I>dspB</I> and <I>nisA</I>. We chose these enzymes to create a hostile environment for these pathogens. Whilst the effects of these molecules differ from each other, a regulated release of these proteins will cause the pathogens to lose their virulence and even kill some of them. Also, the regulated response against these pathogens will reduce the chance of <I>P. aeruginosa</I> and <I>S. aureus</I> to become resistant against these infection preventing molecules. Controlling the virulence with these molecules is key to a good treatment of infected burn wounds.
</DIV></DIV></DIV></DIV><DIV class="module contentmodule gridcell"><DIV class="content"><DIV class="wrapper"><DIV class="title">

Signal peptide of USP45

</DIV><DIV class="text">
AiiA is probably an intracellular enzyme, which makes secreting it kind of hard. Also, it is not quite sure that Dispersin B is secreted and if so, it would have a signal peptide from its host. These are some problems which can sincerely hurt our secretion system. 
The solution is a signal peptide from the gene USP45 which is secreted out of <I>Lactococcus lactis</I> very efficiently. This became clear when scientist fused a couple of genes together with the signal coding sequence of USP45. This resulted in an efficient way of secreting the coded proteins into the media.<SUP>4</SUP>
So how are these enzymes secreted out of the cell when the spUSP45 is fused to the enzymes?
Well, at first this coding sequence of ssUSP45 should be fused together with the genes. Then after translation, the coded enzyme will meet a chaperone protein , called SecB, which bring the secreting enzyme to a protein conducting gate. This gate cleaves the signal peptide and frees the enzyme from the cell.<SUP>5</SUP>
Therefore, we have chosen to fuse all our coding sequences from the enzymes with ssUSP45. 

</DIV></DIV></DIV></DIV><DIV class="module contentmodule gridcell"><DIV class="content"><DIV class="wrapper"><DIV class="title">
The anti-quorum sensing molecule
</DIV><DIV class="subtitle">
AiiA
</DIV><DIV class="text">
Bacteria use certain specific molecules to communicate with each other, also known as quorum sensing molecules. For <I>Pseudomonas aeruginosa</I> one of these molecules is the acylhomoserine lactone (AHL) molecule. This is important because communication between bacteria with these molecules can up-regulate virulence genes<SUP>8</SUP>, thereby worsening the infection.
</DIV><DIV class="text">
AiiA is a molecule that can enzymatically degrade the AHL molecules and thereby inhibit the quorum sensing between the pathogens. The AiiA molecule is part of the lactonase group. These enzymes can cut the ring in the AHL molecules, thereby inactivating the quorum sensing molecules<SUP>9</SUP>. Although quorum sensing is inhibited, these molecules do not interfere with basal life processes such as general RNA and protein synthesis of the bacteria, and growth, therefore it is conceivable that the selective pressure for development of resistance is minimized. 
Inhibiting the quorum sensing between the pathogens has several benefits. One of these benefits is the down regulation of virulence genes. Another benefit is that AiiA will decrease the ability of <I>Pseudomonas aeruginosa</I> to form biofilms, making them more susceptible to conventional antibiotics and the action of the host immune system<SUP>10</SUP>. The inhibition of AHL molecules also disturbs some of the motility of <I>Pseudomonas aeruginosa</I><SUP>11</SUP>. 
</DIV><DIV class="text">
By secreting this molecule through our bandage, the Gram-negative pathogens can be battled. Although we can not kill the pathogens, they will become less virulent, less motile, decrease the ability to form biofilms an thus make them more susceptible to the human immune system.
</DIV></DIV></DIV></DIV><DIV class="module contentmodule gridcell"><DIV class="content"><DIV class="wrapper"><DIV class="title">
The construct
</DIV><DIV class="text">
In order to synchronize the secretion of infection preventing molecules with the detection of the certain pathogens, a few conditions must been set. 
</DIV><UL><LI> The construct should be regulated through detection.
</LI><LI> It must secrete DspB when <I>L. lactis</I> senses both <I>P. aeruginosa</I> and <I>S. aureus</I></LI><LI> It must secrete Aiia when it detect <I> P. aeruginosa</I></LI><LI> It must secrete Nisin when it detects <I>S. aureus</I></LI></UL><DIV class="text">
After designing the systems, two constructs came out:

The anti-<I>Pseudomonas aeruginosa</I> system:


<DIV class="figure"><DIV class="hspacer"> </DIV><DIV class="caption"><SPAN class="title">Figure 6:</SPAN>
The DspB and AiiA construct
</DIV><DIV class="hspacer"> </DIV></DIV><DIV class="hspacer"> </DIV>



The anti-<I>Staphylococcus aureus</I> secretion system: 


<DIV class="figure"><DIV class="hspacer"> </DIV><DIV class="caption"><SPAN class="title">Figure 7:</SPAN>
The DspB and nisin construct
</DIV><DIV class="hspacer"> </DIV></DIV><DIV class="hspacer"> </DIV></DIV></DIV></DIV></DIV><DIV class="module contentmodule gridcell"><DIV class="content"><DIV class="wrapper"><DIV class="title">
Nisin
</DIV><DIV class="text"><I>Lactococcus lactis</I> is capable of producing nisin, an antibiotic-like substance, called a bacteriocin. It is a natural antimicrobial agent with activity against a wide variety of Gram-positive bacteria, including food-borne pathogens such as <I>Listeria</I>, <I>Staphylococcus</I> and <I>Clostridium</I> by targeting the cell membrane<SUP>6</SUP>. The activity of nisin towards Gram-positive bacteria is based on binding of nisin to the lipidII molecule in the cell wall. In this way nisin can inhibit growth of Gram-positive cells in two ways. First it will inhibit cell wall synthesis by binding of the lipidII molecule in the membrane. Secondly, nisin molecules can span across the lipid bilayer, creating a pore in the cell wall which causes the cell to lyse. Both mechanisms are shown in figure 1.<SUP>7</SUP></DIV><DIV class="figure"><DIV class="hspacer"> </DIV><DIV class="caption"><SPAN class="title">Figure 3:</SPAN>
Nisin binding to lipidII in the cell wall, causing pore formation
</DIV><DIV class="hspacer"> </DIV></DIV><DIV class="hspacer"> </DIV><DIV class="text">
By first detecting <I>Staphylococcus aureus</I>, in order to induce the nisin production we will reduce the chance at nisin-resistance. Overall the risk at pathogens becoming resistant to nisin is very low, because lipidII is an essential cell wall protein.  
</DIV></DIV></DIV></DIV></DIV><DIV class="entry grid gridcell last"><DIV class="module imagemodule gridcell"><DIV class="content"><DIV class="wrapper"><DIV class="image"><DIV class="hspacer"> </DIV></DIV><DIV class="hspacer"> </DIV><DIV class="hspacer"> </DIV><DIV class="hspacer"> </DIV></DIV><DIV class="hspacer"> </DIV></DIV><DIV class="hspacer"> </DIV></DIV><DIV class="hspacer"> </DIV><DIV class="module contentmodule gridcell"><DIV class="content"><DIV class="wrapper"><DIV class="title">
Dispersin B
</DIV><DIV class="text">
Certain pathogens protect themselves by producing a extracellular polymeric substance. The bacteria encapsulate themselves with exopolysaccharides which can adhere to other cells with these extracellular “sugars”. The encapsulated pathogen can also become resistant against any type of antibiotics. If a patient becomes infected with these pathogens and the pathogens get the chance to adhere themselves to a surface, curing these infections can become very difficult.
</DIV><DIV class="text">
But before we try to solve this problem, how do biofilms actually form? Well, first certain individual bacteria must adhere to a surface and form micro colonies. These will become the basis of the biofilm. Then motile bacteria will try to migrate to these colonies and adhere themselves on top of the colonies. After a couple of cycles, these bacteria will have formed a mushroom kind of structure, which can release bacteria individuals. These individuals in their turn create their own biofilm. 
</DIV><DIV class="figure"><DIV class="hspacer"> </DIV><DIV class="caption"><SPAN class="title">Figure 4:</SPAN>
The creation of the biofilm
</DIV><DIV class="hspacer"> </DIV></DIV><DIV class="hspacer"> </DIV><DIV class="text">
So we had to think about a strategy to battle these structures. After a lot of research, Dispersin B came to our minds. The enzyme is commonly used by <I>Aggregatibacter actinomycetemcomitans</I>, which is a periodontal pathogen. Dispersin B itself catalyzes the hydrolysis of N-acetyl-D-glucosamine found in the biofilm.  Thereby releasing certain bacteria, which under the right circumstances become very susceptible for antibiotics.  Therefore, there has been a gigantic market opportunity for this enzyme as detergents or medicine. The enzyme is a 361 amino acids counting protein and is 40 kDa big. It hydrolyzes the β-1,6-glycosidic link between the acetylglucosamine polymers in the biofilm matrices. 
The active site contains 3 amino acids which have highly conserved acidic residues. 
The three amino acids are D183, E184 and E322. E184 act as a proton donator to the OR-site of the first carbon in the polymer. D183 assists the activation of the N-acetyl group, which gives of the electron to the first carbon of the polymer, so water can then hydrolyze the polymer. <SUP>3</SUP></DIV><DIV class="figure"><DIV class="hspacer"> </DIV><DIV class="caption"><SPAN class="title">Figure 5:</SPAN>
The reaction between Dispersin B and the poly saccharides.
</DIV><DIV class="hspacer"> </DIV></DIV><DIV class="hspacer"> </DIV><DIV class="text">
The problem with <I>Pseudomonas aeruginosa</I> and <I> Staphylococcus aureus</I> is that they also can produce a biofilm which can protect them against any antimicrobials. 
Because of the limitations on obtaining a gene from a ML-II bacteria, we decided to
 synthesize this gene, with the ssUSP45 and 6xhistidine tag already attached. 
We decide to attach the HIS tag because of some logistic reasons concerning PCR and Gibson assembly.

</DIV></DIV></DIV></DIV><DIV class="module contentmodule gridcell"><DIV class="content"><DIV class="wrapper"><DIV class="title">
The construct
</DIV><DIV class="text">
In order to synchronize the secretion of infection preventing molecules with the detection of the certain pathogens, a few conditions must been set. 
</DIV><UL><LI> The construct should be regulated through detection.
</LI><LI> It must secrete DspB when <I>L. lactis</I> senses both <I>P. aeruginosa</I> and <I>S. aureus</I></LI><LI> It must secrete Aiia when it detect <I> P. aeruginosa</I></LI><LI> It must secrete Nisin when it detects <I>S. aureus</I></LI></UL><DIV class="text">
After designing the systems, two constructs came out:

The anti-<I>Pseudomonas aeruginosa</I> system:


<DIV class="figure"><DIV class="hspacer"> </DIV><DIV class="caption"><SPAN class="title">Figure 6:</SPAN>
The DspB and AiiA construct
</DIV><DIV class="hspacer"> </DIV></DIV><DIV class="hspacer"> </DIV>



The anti-<I>Staphylococcus aureus</I> secretion system: 


<DIV class="figure"><DIV class="hspacer"> </DIV><DIV class="caption"><SPAN class="title">Figure 7:</SPAN>
The DspB and nisin construct
</DIV><DIV class="hspacer"> </DIV></DIV><DIV class="hspacer"> </DIV></DIV></DIV></DIV></DIV><DIV class="module referencemodule gridcell"><DIV class="content"><DIV class="wrapper"><DIV class="title">References</DIV><DIV class="hspacer"> </DIV><DIV class="reference">
1. Bjarnsholt, T. (2013) The role of bacterial biofilms in chronic infections. <I>APMIS</I> 121: 1-58
</DIV><DIV class="hspacer"> </DIV><DIV class="reference">
2. Davis, D. (2007) Looking for chinks in the armor of bacterial biofilms. <I>PLoS Biology</I> 5
</DIV><DIV class="hspacer"> </DIV><DIV class="reference">
3.Mark, B.L. et al. (2001) Crystallographic evidence for substrate-assisted catalysis in a bacterial beta-hexosaminidase. <I>J. Biol. Chem.</I> 276: 10330–10337
</DIV><DIV class="hspacer"> </DIV><DIV class="reference">
4. Asseldonk, M., De Vos, W.M., and Simons, G. (1993) Functional analysis of the <I>Lactococcus lactis</I> usp45 secretion signal in the secretion of a homologous proteinase and a heterologous a-amylase. <I>Mol. Gen. Genet.</I> 240: 428-434. 
</DIV><DIV class="hspacer"> </DIV><DIV class="reference">
5. Natale, P. et al. (2008) Sec- and Tat-mediated protein secretion across the bacterial cytoplasmic membrane— Distinct translocases and mechanism. <I>Bioch. Bioph. Acta</I> 1778:1735–1756
</DIV><DIV class="hspacer"> </DIV><DIV class="reference">
6. Todar, K. <I>Lactococcus lactis</I>: nominated as the Wisconsin State Microbe. Online textbook of microbiology,  UW Department of Bacteriology
</DIV><DIV class="hspacer"> </DIV><DIV class="reference">
7. Wiedemann, I. (2001) Specific binding of nisin to the peptidoglycan precursor Lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. <I>J. Biol. Chem.</I> 276: 1772-1779
</DIV><DIV class="hspacer"> </DIV><DIV class="reference">
8. Dong, Y.H. et al. (2000) AiiA, an enzyme that inactivates the acylhomoserine lactone quorum-sensing signal and attenuates the virulence of <I>Erwinia carotovora</I>. <I>PNAS</I> 97: 3526-3531
</DIV><DIV class="hspacer"> </DIV><DIV class="reference">
9. Kim, M.H. et al. (2005) The molecular structure and catalytic mechanism of a quorum-quenching N-acyl-L-homoserine lactone hydrolase. <I>PNAS</I> 102
</DIV><DIV class="hspacer"> </DIV><DIV class="reference">
10. Rasmussen, T.B. and Givskov, M. (2006) Quorum sensing inhibitors: a bargain of effects. <I>Microbiol.</I> 152: 895-904
</DIV><DIV class="hspacer"> </DIV><DIV class="reference">
11. Reimmann, C. et al. (2002) Genetically programmed autoinducer destruction reduces virulence gene expression and swarming motility in <I>Pseudomonas aeruginosa</I> PAO1. <I>Microbiol.</I> 148: 923-932
</DIV><DIV class="hspacer"> </DIV><DIV class="hspacer"> </DIV></DIV><DIV class="hspacer"> </DIV></DIV><DIV class="hspacer"> </DIV></DIV></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2014.igem.org/Team:Groningen/Template/MODULE/Project/secretion">http://2014.igem.org/Team:Groningen/Template/MODULE/Project/secretion</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Groningen/Template/MODULE/Project/secretion" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Groningen/Template/MODULE/Project/secretion" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Groningen/Template/MODULE/Project/secretion&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Groningen/Template/MODULE/Project/secretion&amp;oldid=392794" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2014.igem.org:Privacy_policy" title="2014.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2014.igem.org:General_disclaimer" title="2014.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>